On ECHEMI
Home > Drugs > Metformin hydrochloride Registered Holders
Metformin hydrochloride structure

Metformin hydrochloride structure

Metformin hydrochloride

Metformin (hydrochloride) is an FDA approved first-line drug for the treatment of type 2 diabetes. Metformin decreases hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory-chain complex 1.

Find 58 Related Holders

TAPI PUERTO RICO, INC.
European Union European Union

API Registration Country

API Inactive
INDOCO REMEDIES LIMITED
European Union European Union

API Registration Country

API Inactive
Coral Drugs Private Ltd
European Union European Union

API Registration Country

API Inactive
SHANDONG KEYUAN PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Inactive
AURO LABORATORIES LTD
United States United States

API Registration Country

API Inactive
NOVUS FINE CHEMICALS LLC
United States United States

API Registration Country

API Inactive
VIBRANTIS SA DE CV
United States United States

API Registration Country

API Inactive
GROUPE LIPHA
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Metformin hydrochloride
View 136 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.